![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: OBGYN
April 9, 2025
From Good to Great: Continuous Improvement of Our High-Risk Women’s Program
Lisa McGuire analyzes the oncology program at HCA Florida Ocala before and after their breast cancer risk assessment program implemented CARE.
OBGYN
December 18, 2024
Enhancing Patient Care: A Digital Approach via The Ambry CARE Program® Improves Universal Cancer Risk Stratification in Imaging Centers
A retrospective study across 15 Imaging Centers assesses the transition of a paper screening cancer risk assessment tool to a universally accessible tool on a…
Genetic Testing
Hereditary Cancer
OBGYN
Screening
July 17, 2024
Expanding Your High-Risk Breast Program: Best Practices for Growth and Impact
Nurse Adrianne Alexander shares practical, engaging, and impactful best practices to expand a high-risk breast program.
BRCA1 & 2
Breast Cancer
Breast Cancer Awareness
Cancer Risk
Genetic Testing
OBGYN
Risk Factors
June 20, 2024
From Vision to Reality: Best Practices for Building High-Risk Breast Programs
A high-risk breast program is designed to identify patients with an elevated risk of developing breast cancer and then offering genetic counseling, genetic testing, additional…
Breast Cancer
Breast Cancer Awareness
Genetic Testing
OBGYN
April 30, 2024
Advancing Equity: TriHealth’s Experience Leveraging CARE to Standardize Cancer Risk Assessment
Chelsea Menke, MS, CGC, discusses addressing health inequalities at TriHealth gynecology clinic with the Ambry CARE Program.
Genetic Discrimination
Genetic Testing
Genetic Testing Accuracy
OBGYN
February 7, 2024
CARE Patient Examples at Lake Health
Dr. Liese Vito shares examples of hereditary cancer testing at Lake Health for patients with a BRCA+ and PMS2 mutation and the preventative healthcare measures…
BRCA1 & 2
Breast Cancer
Colorectal Cancer
Genetic Testing
Hereditary Cancer
OBGYN
Ovarian Cancer
